Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3097 to 3108 of 3128 entries
Sorted by: Best Match Show Resources per page
Recall of Genomic Testing Results Among Patients with Cancer.

The oncologist

Wing SE, Hu H, Lopez L, Solomon I, Shen J, Raquel C, Sur M, Chao J, Cristea M, Fakih M, Mortimer J, Pal S, Reckamp K, Yuan Y, Gray SW.
PMID: 34355454
Oncologist. 2021 Dec;26(12):e2302-e2305. doi: 10.1002/onco.13928. Epub 2021 Aug 26.

BACKGROUND: Genomic testing of somatic and germline DNA has transformed cancer care. However, low genetic knowledge among patients may compromise care and health outcomes. Given the rise in genomic testing, we sought to understand patients' knowledge of their genetic...

Cite
Wing SE, Hu H, Lopez L, et al. Recall of Genomic Testing Results Among Patients with Cancer. Oncologist. 2021;26(12):e2302-e2305doi: 10.1002/onco.13928.
Wing, S. E., Hu, H., Lopez, L., Solomon, I., Shen, J., Raquel, C., Sur, M., Chao, J., Cristea, M., Fakih, M., Mortimer, J., Pal, S., Reckamp, K., Yuan, Y., & Gray, S. W. (2021). Recall of Genomic Testing Results Among Patients with Cancer. The oncologist, 26(12), e2302-e2305. https://doi.org/10.1002/onco.13928
Wing, Sam E, et al. "Recall of Genomic Testing Results Among Patients with Cancer." The oncologist vol. 26,12 (2021): e2302-e2305. doi: https://doi.org/10.1002/onco.13928
Wing SE, Hu H, Lopez L, Solomon I, Shen J, Raquel C, Sur M, Chao J, Cristea M, Fakih M, Mortimer J, Pal S, Reckamp K, Yuan Y, Gray SW. Recall of Genomic Testing Results Among Patients with Cancer. Oncologist. 2021 Dec;26(12):e2302-e2305. doi: 10.1002/onco.13928. Epub 2021 Aug 26. PMID: 34355454.
Copy Download .nbib Format: NLM
Developing an Index of Medical Conditions Associated with Outcomes after Moderate-to-Severe Traumatic Brain Injury.

Journal of neurotrauma

Whiteneck GG, Ketchum JM, Almeida EJ, Goldstein R, Brown AW, Corrigan JD, Hammond FM, Weintraub AH, Tefertiller C.
PMID: 33256501
J Neurotrauma. 2021 Mar;38(5):593-603. doi: 10.1089/neu.2020.7366. Epub 2021 Jan 07.

Medical conditions co-occurring with traumatic brain injury (TBI) are associated with outcomes, and comorbidity indices such as Charlson and Elixhauser are used in TBI research, but they are not TBI specific. The purpose of this research was to develop...

Cite
Whiteneck GG, Ketchum JM, Almeida EJ, et al. Developing an Index of Medical Conditions Associated with Outcomes after Moderate-to-Severe Traumatic Brain Injury. J Neurotrauma. 2021;38(5):593-603doi: 10.1089/neu.2020.7366.
Whiteneck, G. G., Ketchum, J. M., Almeida, E. J., Goldstein, R., Brown, A. W., Corrigan, J. D., Hammond, F. M., Weintraub, A. H., & Tefertiller, C. (2021). Developing an Index of Medical Conditions Associated with Outcomes after Moderate-to-Severe Traumatic Brain Injury. Journal of neurotrauma, 38(5), 593-603. https://doi.org/10.1089/neu.2020.7366
Whiteneck, Gale G, et al. "Developing an Index of Medical Conditions Associated with Outcomes after Moderate-to-Severe Traumatic Brain Injury." Journal of neurotrauma vol. 38,5 (2021): 593-603. doi: https://doi.org/10.1089/neu.2020.7366
Whiteneck GG, Ketchum JM, Almeida EJ, Goldstein R, Brown AW, Corrigan JD, Hammond FM, Weintraub AH, Tefertiller C. Developing an Index of Medical Conditions Associated with Outcomes after Moderate-to-Severe Traumatic Brain Injury. J Neurotrauma. 2021 Mar;38(5):593-603. doi: 10.1089/neu.2020.7366. Epub 2021 Jan 07. PMID: 33256501.
Copy Download .nbib Format: NLM
Pharmacokinetics of vaginally applied integrase inhibitors in macaques.

The Journal of antimicrobial chemotherapy

Nishiura K, Sharma S, Sterling M, Makarova N, Martin A, Dinh C, Mitchell J, García-Lerma JG, Heneine W, Dobard C.
PMID: 34423357
J Antimicrob Chemother. 2021 Oct 11;76(11):2894-2901. doi: 10.1093/jac/dkab293.

OBJECTIVES: We conducted a detailed pharmacokinetic assessment in macaques treated with vaginal gels formulated with HIV integrase strand transfer inhibitors (INSTIs) to better understand drug distribution and identify INSTI concentrations associated with previously demonstrated in vivo protection against vaginal...

Cite
Nishiura K, Sharma S, Sterling M, et al. Pharmacokinetics of vaginally applied integrase inhibitors in macaques. J Antimicrob Chemother. 2021;76(11):2894-2901doi: 10.1093/jac/dkab293.
Nishiura, K., Sharma, S., Sterling, M., Makarova, N., Martin, A., Dinh, C., Mitchell, J., García-Lerma, J. G., Heneine, W., & Dobard, C. (2021). Pharmacokinetics of vaginally applied integrase inhibitors in macaques. The Journal of antimicrobial chemotherapy, 76(11), 2894-2901. https://doi.org/10.1093/jac/dkab293
Nishiura, Kenji, et al. "Pharmacokinetics of vaginally applied integrase inhibitors in macaques." The Journal of antimicrobial chemotherapy vol. 76,11 (2021): 2894-2901. doi: https://doi.org/10.1093/jac/dkab293
Nishiura K, Sharma S, Sterling M, Makarova N, Martin A, Dinh C, Mitchell J, García-Lerma JG, Heneine W, Dobard C. Pharmacokinetics of vaginally applied integrase inhibitors in macaques. J Antimicrob Chemother. 2021 Oct 11;76(11):2894-2901. doi: 10.1093/jac/dkab293. PMID: 34423357.
Copy Download .nbib Format: NLM
Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale.

International journal of environmental research and public health

Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB.
PMID: 33806834
Int J Environ Res Public Health. 2021 Mar 23;18(6). doi: 10.3390/ijerph18063298.

Among transgender and gender diverse people, psychological gender affirmation is an internal sense of valuing oneself as a transgender or gender diverse person, being comfortable with one's gender identity, and feeling satisfied with one's body and gender expression. Gender...

Cite
Sevelius JM, Chakravarty D, Dilworth SE, et al. Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale. Int J Environ Res Public Health. 2021;18(6)doi: 10.3390/ijerph18063298.
Sevelius, J. M., Chakravarty, D., Dilworth, S. E., Rebchook, G., & Neilands, T. B. (2021). Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale. International journal of environmental research and public health, 18(6), . https://doi.org/10.3390/ijerph18063298
Sevelius, Jae M, et al. "Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale." International journal of environmental research and public health vol. 18,6 (2021). doi: https://doi.org/10.3390/ijerph18063298
Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Measuring Satisfaction and Comfort with Gender Identity and Gender Expression among Transgender Women: Development and Validation of the Psychological Gender Affirmation Scale. Int J Environ Res Public Health. 2021 Mar 23;18(6). doi: 10.3390/ijerph18063298. PMID: 33806834; PMCID: PMC8005192.
Copy Download .nbib Format: NLM
Developing Initial Middle Range Theories in Realist Evaluation: A Case of an Organisational Intervention.

International journal of environmental research and public health

Roodbari H, Nielsen K, Axtell C, Peters SE, Sorensen G.
PMID: 34444110
Int J Environ Res Public Health. 2021 Aug 07;18(16). doi: 10.3390/ijerph18168360.

(1) Background: Realist evaluation is a promising approach for evaluating organisational interventions. Crucial to realist evaluation is the development and testing of middle range theories (MRTs). MRTs are programme theories that outline how the intervention mechanisms work in a...

Cite
Roodbari H, Nielsen K, Axtell C, et al. Developing Initial Middle Range Theories in Realist Evaluation: A Case of an Organisational Intervention. Int J Environ Res Public Health. 2021;18(16)doi: 10.3390/ijerph18168360.
Roodbari, H., Nielsen, K., Axtell, C., Peters, S. E., & Sorensen, G. (2021). Developing Initial Middle Range Theories in Realist Evaluation: A Case of an Organisational Intervention. International journal of environmental research and public health, 18(16), . https://doi.org/10.3390/ijerph18168360
Roodbari, Hamid, et al. "Developing Initial Middle Range Theories in Realist Evaluation: A Case of an Organisational Intervention." International journal of environmental research and public health vol. 18,16 (2021). doi: https://doi.org/10.3390/ijerph18168360
Roodbari H, Nielsen K, Axtell C, Peters SE, Sorensen G. Developing Initial Middle Range Theories in Realist Evaluation: A Case of an Organisational Intervention. Int J Environ Res Public Health. 2021 Aug 07;18(16). doi: 10.3390/ijerph18168360. PMID: 34444110; PMCID: PMC8394353.
Copy Download .nbib Format: NLM
A Realist Evaluation of Team Interventions in Acute Hospital Contexts-Use of Two Case Studies to Test Initial Programme Theories.

International journal of environmental research and public health

Cunningham U, De Brún A, Willgerodt M, Abu-Rish Blakeney E, McAuliffe E.
PMID: 34444352
Int J Environ Res Public Health. 2021 Aug 14;18(16). doi: 10.3390/ijerph18168604.

BACKGROUND: Designing and implementing team interventions to improve quality and safety of care in acute hospital contexts is challenging. There is little emphasis in the literature on how contextual conditions impact interventions or how specific active ingredients of interventions...

Cite
Cunningham U, De Brún A, Willgerodt M, et al. A Realist Evaluation of Team Interventions in Acute Hospital Contexts-Use of Two Case Studies to Test Initial Programme Theories. Int J Environ Res Public Health. 2021;18(16)doi: 10.3390/ijerph18168604.
Cunningham, U., De Brún, A., Willgerodt, M., Abu-Rish Blakeney, E., & McAuliffe, E. (2021). A Realist Evaluation of Team Interventions in Acute Hospital Contexts-Use of Two Case Studies to Test Initial Programme Theories. International journal of environmental research and public health, 18(16), . https://doi.org/10.3390/ijerph18168604
Cunningham, Una, et al. "A Realist Evaluation of Team Interventions in Acute Hospital Contexts-Use of Two Case Studies to Test Initial Programme Theories." International journal of environmental research and public health vol. 18,16 (2021). doi: https://doi.org/10.3390/ijerph18168604
Cunningham U, De Brún A, Willgerodt M, Abu-Rish Blakeney E, McAuliffe E. A Realist Evaluation of Team Interventions in Acute Hospital Contexts-Use of Two Case Studies to Test Initial Programme Theories. Int J Environ Res Public Health. 2021 Aug 14;18(16). doi: 10.3390/ijerph18168604. PMID: 34444352; PMCID: PMC8393900.
Copy Download .nbib Format: NLM
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer.

Gut

Chen H, Zheng X, Zong X, Li Z, Li N, Hur J, Fritz CD, Chapman W, Nickel KB, Tipping A, Colditz GA, Giovannucci EL, Olsen MA, Fields RC, Cao Y.
PMID: 33037055
Gut. 2021 Jun;70(6):1147-1154. doi: 10.1136/gutjnl-2020-321661. Epub 2020 Oct 09.

OBJECTIVE: Factors that lead to metabolic dysregulation are associated with increased risk of early-onset colorectal cancer (CRC diagnosed under age 50). However, the association between metabolic syndrome (MetS) and early-onset CRC remains unexamined.DESIGN: We conducted a nested case-control study...

Cite
Chen H, Zheng X, Zong X, et al. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut. 2020;70(6):1147-1154doi: 10.1136/gutjnl-2020-321661.
Chen, H., Zheng, X., Zong, X., Li, Z., Li, N., Hur, J., Fritz, C. D., Chapman, W., Nickel, K. B., Tipping, A., Colditz, G. A., Giovannucci, E. L., Olsen, M. A., Fields, R. C., & Cao, Y. (2021). Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut, 70(6), 1147-1154. https://doi.org/10.1136/gutjnl-2020-321661
Chen, Hanyu, et al. "Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer." Gut vol. 70,6 (2021): 1147-1154. doi: https://doi.org/10.1136/gutjnl-2020-321661
Chen H, Zheng X, Zong X, Li Z, Li N, Hur J, Fritz CD, Chapman W, Nickel KB, Tipping A, Colditz GA, Giovannucci EL, Olsen MA, Fields RC, Cao Y. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut. 2021 Jun;70(6):1147-1154. doi: 10.1136/gutjnl-2020-321661. Epub 2020 Oct 09. PMID: 33037055; PMCID: PMC8032822.
Copy Download .nbib Format: NLM
Health, Neighborhoods, and School Readiness from the Parent Perspective: A Qualitative Study of Contextual and Socio-Emotional Factors.

International journal of environmental research and public health

Dunaway LEF, Bazzano AN, Gray SAO, Theall KP.
PMID: 34501939
Int J Environ Res Public Health. 2021 Sep 04;18(17). doi: 10.3390/ijerph18179350.

The objective of this qualitative study was to address existing gaps in the literature by gathering parent perspectives on both health and school readiness in regard to neighborhood context, specifically parents' perceived level of neighborhood safety and support, on...

Cite
Dunaway LEF, Bazzano AN, Gray SAO, et al. Health, Neighborhoods, and School Readiness from the Parent Perspective: A Qualitative Study of Contextual and Socio-Emotional Factors. Int J Environ Res Public Health. 2021;18(17)doi: 10.3390/ijerph18179350.
Dunaway, L. E. F., Bazzano, A. N., Gray, S. A. O., & Theall, K. P. (2021). Health, Neighborhoods, and School Readiness from the Parent Perspective: A Qualitative Study of Contextual and Socio-Emotional Factors. International journal of environmental research and public health, 18(17), . https://doi.org/10.3390/ijerph18179350
Dunaway, Lauren E Futrell, et al. "Health, Neighborhoods, and School Readiness from the Parent Perspective: A Qualitative Study of Contextual and Socio-Emotional Factors." International journal of environmental research and public health vol. 18,17 (2021). doi: https://doi.org/10.3390/ijerph18179350
Dunaway LEF, Bazzano AN, Gray SAO, Theall KP. Health, Neighborhoods, and School Readiness from the Parent Perspective: A Qualitative Study of Contextual and Socio-Emotional Factors. Int J Environ Res Public Health. 2021 Sep 04;18(17). doi: 10.3390/ijerph18179350. PMID: 34501939; PMCID: PMC8430681.
Copy Download .nbib Format: NLM
Preliminary Risk assessment for Acrylamide and Peripheral Neuropathy.

Neurotoxicology

Park RM.
PMID: 33892018
Neurotoxicology. 2021 Jul;85:10-17. doi: 10.1016/j.neuro.2021.04.004. Epub 2021 Apr 20.

Acrylamide (ACM) is a high-volume industrial chemical with diverse uses in manufacturing, construction and laboratory research. ACM is a well-established neurotoxic agent causing peripheral neuropathy with impairment in the arms and legs of exposed workers, most thoroughly studied in...

Cite
Park RM. Preliminary Risk assessment for Acrylamide and Peripheral Neuropathy. Neurotoxicology. 2021;85:10-17doi: 10.1016/j.neuro.2021.04.004.
Park, R. M. (2021). Preliminary Risk assessment for Acrylamide and Peripheral Neuropathy. Neurotoxicology, 8510-17. https://doi.org/10.1016/j.neuro.2021.04.004
Park, Robert M. "Preliminary Risk assessment for Acrylamide and Peripheral Neuropathy." Neurotoxicology vol. 85 (2021): 10-17. doi: https://doi.org/10.1016/j.neuro.2021.04.004
Park RM. Preliminary Risk assessment for Acrylamide and Peripheral Neuropathy. Neurotoxicology. 2021 Jul;85:10-17. doi: 10.1016/j.neuro.2021.04.004. Epub 2021 Apr 20. PMID: 33892018; PMCID: PMC8284192.
Copy Download .nbib Format: NLM
Evidence in oncology. The Janeway lecture 2000.

Cancer journal (Sudbury, Mass.)

Cox JD.
PMID: 11131481
Cancer J. 2000 Nov-Dec;6(6):351-7.

PURPOSE: The purpose of this address is to evaluate the types of evidence that have fashioned clinical decision making in oncology over the past century and to determine the appropriate weighting of evidence at the start of a new...

Cite
Cox JD. Evidence in oncology. The Janeway lecture 2000. Cancer J. 2000;6(6):351-7
Cox, J. D. (2000). Evidence in oncology. The Janeway lecture 2000. Cancer journal (Sudbury, Mass.), 6(6), 351-7.
Cox, J D. "Evidence in oncology. The Janeway lecture 2000." Cancer journal (Sudbury, Mass.) vol. 6,6 (2000): 351-7.
Cox JD. Evidence in oncology. The Janeway lecture 2000. Cancer J. 2000 Nov-Dec;6(6):351-7. PMID: 11131481.
Copy Download .nbib Format: NLM
Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities.

Drug and alcohol dependence

Morean ME, Davis DR, Kong G, Bold KW, Camenga DR, Suttiratana S, Lee J, Rajeshkumar L, Krishnan-Sarin S.
PMID: 34607191
Drug Alcohol Depend. 2021 Nov 01;228:109104. doi: 10.1016/j.drugalcdep.2021.109104. Epub 2021 Sep 27.

BACKGROUND: Vaping is the second most common modality of using cannabis following smoking. We examined differences in demographics and substance use behaviors between adolescent cannabis vapers and those exclusively using other cannabis modalities.METHODS: In 2019, 4875 students from six...

Cite
Morean ME, Davis DR, Kong G, et al. Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities. Drug Alcohol Depend. 2021;228:109104doi: 10.1016/j.drugalcdep.2021.109104.
Morean, M. E., Davis, D. R., Kong, G., Bold, K. W., Camenga, D. R., Suttiratana, S., Lee, J., Rajeshkumar, L., & Krishnan-Sarin, S. (2021). Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities. Drug and alcohol dependence, 228109104. https://doi.org/10.1016/j.drugalcdep.2021.109104
Morean, Meghan E, et al. "Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities." Drug and alcohol dependence vol. 228 (2021): 109104. doi: https://doi.org/10.1016/j.drugalcdep.2021.109104
Morean ME, Davis DR, Kong G, Bold KW, Camenga DR, Suttiratana S, Lee J, Rajeshkumar L, Krishnan-Sarin S. Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities. Drug Alcohol Depend. 2021 Nov 01;228:109104. doi: 10.1016/j.drugalcdep.2021.109104. Epub 2021 Sep 27. PMID: 34607191; PMCID: PMC8595758.
Copy Download .nbib Format: NLM
P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance.

The Journal of experimental medicine

He Y, Gallman AE, Xie C, Shen Q, Ma J, Wolfreys FD, Sandy M, Arsov T, Wu X, Qin Y, Zhang P, Jiang S, Stanley M, Wu P, Tan J, Ding H, Xue H, Chen W, Xu J, Criswell LA, Nititham J, Adamski M, Kitching AR, Cook MC, Cao L, Shen N, Cyster JG, Vinuesa CG.
PMID: 34889940
J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20211004. Epub 2021 Dec 10.

B cell self-tolerance is maintained through multiple checkpoints, including restraints on intracellular signaling and cell trafficking. P2RY8 is a receptor with established roles in germinal center (GC) B cell migration inhibition and growth regulation. Somatic P2RY8 variants are common...

Cite
He Y, Gallman AE, Xie C, et al. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med. 2021;219(1)doi: 10.1084/jem.20211004.
He, Y., Gallman, A. E., Xie, C., Shen, Q., Ma, J., Wolfreys, F. D., Sandy, M., Arsov, T., Wu, X., Qin, Y., Zhang, P., Jiang, S., Stanley, M., Wu, P., Tan, J., Ding, H., Xue, H., Chen, W., Xu, J., Criswell, L. A., Nititham, J., Adamski, M., Kitching, A. R., Cook, M. C., Cao, L., Shen, N., Cyster, J. G., & Vinuesa, C. G. (2022). P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. The Journal of experimental medicine, 219(1), . https://doi.org/10.1084/jem.20211004
He, Yuke, et al. "P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance." The Journal of experimental medicine vol. 219,1 (2022). doi: https://doi.org/10.1084/jem.20211004
He Y, Gallman AE, Xie C, Shen Q, Ma J, Wolfreys FD, Sandy M, Arsov T, Wu X, Qin Y, Zhang P, Jiang S, Stanley M, Wu P, Tan J, Ding H, Xue H, Chen W, Xu J, Criswell LA, Nititham J, Adamski M, Kitching AR, Cook MC, Cao L, Shen N, Cyster JG, Vinuesa CG. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20211004. Epub 2021 Dec 10. PMID: 34889940; PMCID: PMC8669517.
Copy Download .nbib Format: NLM
Showing 3097 to 3108 of 3128 entries